학술논문
Efficacy and safety of antiCD20 monoclonal antibody divozilimab during 48-week treatment of multiple sclerosis patients in randomized double-blind placebo-controlled clinical trial BCD-132-4/MIRANTIBUS
Document Type
Article
Author
Boyko, A.N.; Alifirova, V.M.; Lukashevich, I.G.; Goncharova, Z.A.; Greshnova, I.V.; Zaslavsky, L.G.; Kotov, S.V.; Malkova, N.A.; Mishin, G.N.; Parshina, E.V.; Poverennova, I.Y.; Prakhova, L.N.; Sivertseva, S.A.; Smagina, I.V.; Totolyan, N.A.; Trinitatsky, Y.V.; Trushnikova, T.N.; Khabirov, F.A.; Chefranova, J.Y.; Shchur, S.G.; Dudin, V.A.; Pokhabov, D.V.; Bolsun, D.D.; Eremeeva, A.V.; Linkova, Y.N.; Zinkina-Orikhan, A.V.
Source
In: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova . (Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2023, 123(7 Vyp 2):43-52)
Subject
Language
English
Russian
Russian
ISSN
19977298